跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,553 条关于
“IL-15 receptor”
全部
20,553
临床试验
8,372
药物
2,320
机构
154
资讯
9,707
去年
ImmunityBio's Anktiva Receives EMA Review for Bladder Cancer Treatment
5个月前
ImmunityBio Secures $100 Million in Financing to Support Global Expansion of ANKTIVA Immunotherapy
去年
ImmunityBio Launches Phase 2 Trial of ANKTIVA for Long COVID Treatment
6个月前
ImmunityBio Achieves Manufacturing Breakthrough for NK Cell Therapy Platform with Scalable Production Process
去年
FDA Approves ImmunityBio's Bladder Cancer Drug After Second Review
去年
Breakthroughs in Bladder Cancer Treatment Highlighted in 2024
去年
Nektar Therapeutics to Report Phase 2b Atopic Dermatitis Trial Results for Novel Regulatory T-Cell Therapy
2年前
FDA Approves First Bispecific T-Cell Engager for Solid Tumors and Expands Indications for Immunotherapies
9个月前
Nektar Therapeutics to Report Phase 2b Results for Alopecia Areata Treatment Rezpegaldesleukin
去年
FDA Approvals in 2024: Novel Therapies for MASH, WHIM Syndrome, Pediatric Glioma, MDS, and Bladder Cancer
第 1 页,共 971 页
上一页
下一页